# ELEVATE Early LEvosimendan Vs Usual Care in Advanced Chronic hearT failurE

> **NCT01290146** · PHASE3 · TERMINATED · sponsor: **Niguarda Hospital** · enrollment: 13 (actual)

## Conditions studied

- Advanced Chronic Heart Failure

## Interventions

- **DRUG:** Diuretics
- **DRUG:** Levosimendan

## Key facts

- **NCT ID:** NCT01290146
- **Lead sponsor:** Niguarda Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2011-02
- **Primary completion:** 2015-06
- **Final completion:** 2017-03
- **Target enrollment:** 13 (ACTUAL)
- **Why stopped:** Due to lack of enrollment
- **Last updated:** 2017-04-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01290146

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01290146, "ELEVATE Early LEvosimendan Vs Usual Care in Advanced Chronic hearT failurE". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01290146. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*